Lindbrook Capital, LLC Biotechnology

Lindbrook Capital, LLC

$1.06 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DAWN Day One Biopharmaceuticals, Inc.	$514M	$1,000 0.0% of portfolio	142	Q1 2025 New
KROS Keros Therapeutics, Inc.	$345M	$1,000 0.0% of portfolio	165	Q1 2025 Added 85.39%
NUVL Nuvalent, Inc.	$3.35B	$1,000 0.0% of portfolio	16	Q1 2025 Added 433.33%
OMER Omeros Corp	$193M	$1,000 0.0% of portfolio	122	Q1 2025 New
ORIC Oric Pharmaceuticals, Inc.	$426M	$1,000 0.0% of portfolio	319	Q1 2025 Added 49.07%
PHAT Phathom Pharmaceuticals, Inc.	$344M	$1,000 0.0% of portfolio	254	Q1 2025 Added 63.87%
PGEN Precigen, Inc.	$341M	$1,000 0.0% of portfolio	946	Q1 2025 New
RGNX Regenxbio Inc.	$396M	$1,000 0.0% of portfolio	153	Q1 2025 New
VCEL Vericel Corp	$1.96B	$1,000 0.0% of portfolio	26	Q1 2025 Added 116.67%
ABSI Absci Corp	$248M	$0 0.0% of portfolio	38	Q1 2025 New
ADAP Adaptimmune Therapeutics PLC	$39.2M	$0 0.0% of portfolio	4,610	Q4 2024 Reduced 4.89%
ALT Altimmune, Inc.	$217M	$0 0.0% of portfolio	3	Q1 2025 Reduced 95.08%
ABUS Arbutus Biopharma Corp	$471M	$0 0.0% of portfolio	284	Q4 2023 New
ARCT Arcturus Therapeutics Holdings Inc.	$355M	$0 0.0% of portfolio	86	Q1 2025 New
RCUS Arcus Biosciences, Inc.	$673M	$0 0.0% of portfolio	13	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	758	Q1 2025 Reduced 5.84%
ARVN Arvinas, Inc.	$438M	$0 0.0% of portfolio	97	Q1 2025 Reduced 66.67%
AURA Aura Biosciences, Inc.	$180M	$0 0.0% of portfolio	140	Q1 2025 New
AXLA Axcella Health Inc.	$0	$0 0.0% of portfolio	80	Q3 2023 Reduced 96.0%
CAPR Capricor Therapeutics, Inc.	$249M	$0 0.0% of portfolio	52	Q1 2025 New
CMRX Chimerix Inc	$748M	$0 0.0% of portfolio	108	Q1 2025 New
CRMD Cor Medix Inc.	$465M	$0 0.0% of portfolio	81	Q3 2024 New
CRSP Crispr Therapeutics Ag	$4.69B	$0 0.0% of portfolio	26	Q1 2025 Reduced 50.0%
HUMA Humacyte, Inc.	$249M	$0 0.0% of portfolio	382	Q1 2025 New
IMNM Immunome Inc.	$104M	$0 0.0% of portfolio	102	Q1 2025 New
JANX Janux Therapeutics, Inc.	$998M	$0 0.0% of portfolio	14	Q1 2025 Added 16.67%
LCTX Lineage Cell Therapeutics, Inc.	$166M	$0 0.0% of portfolio	29	Q1 2024 Reduced 98.35%
LQDA Liquidia Corp	$801M	$0 0.0% of portfolio	10	Q1 2025 New
MNKD Mannkind Corp	$983M	$0 0.0% of portfolio	98	Q1 2025 Reduced 67.33%
MLTX Moon Lake Immunotherapeutics	$1.81B	$0 0.0% of portfolio	4	Q1 2025 New
NUVB Nuvation Bio Inc.	$452M	$0 0.0% of portfolio	74	Q1 2025 New
OCUL Ocular Therapeutix, Inc	$770M	$0 0.0% of portfolio	117	Q1 2025 Added 72.06%
SAGE Sage Therapeutics, Inc.	$547M	$0 0.0% of portfolio	67	Q1 2025 New
TSHA Taysha Gene Therapies, Inc.	$117M	$0 0.0% of portfolio	435	Q1 2025 Reduced 43.51%
VERA Vera Therapeutics, Inc.	$619M	$0 0.0% of portfolio	28	Q1 2025 Added 133.33%
XNCR Xencor Inc	$557M	$0 0.0% of portfolio	34	Q1 2025 Reduced 49.25%
XERS Xeris Biopharma Holdings, Inc.	$636M	$0 0.0% of portfolio	28	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.